Cargando…
Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor
Rationale: The type I insulin-like growth factor receptor (IGF-1R) signaling pathway plays key roles in the development and progression of numerous types of human cancers, and Src and AXL have been found to confer resistance to anti-IGF-1R therapies. Hence, co-targeting Src and AXL may be an effecti...
Autores principales: | Lee, Ho Jin, Pham, Phuong Chi, Pei, Honglan, Lim, Bumhee, Hyun, Seung Yeob, Baek, Byungyeob, Kim, Byungjin, Kim, Yunha, Kim, Min-Hwan, Kang, Nae-Won, Min, Hye-Young, Kim, Dae-Duk, Lee, Jeeyeon, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778606/ https://www.ncbi.nlm.nih.gov/pubmed/33408789 http://dx.doi.org/10.7150/thno.48865 |
Ejemplares similares
-
Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
por: Lee, Ho Jin, et al.
Publicado: (2018) -
Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
por: Lee, Ho Jin, et al.
Publicado: (2023) -
7-Chloro-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidine
por: Bassoude, Ibtissam, et al.
Publicado: (2013) -
Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies
por: Aljohani, Ahmed K. B., et al.
Publicado: (2023) -
Ethyl 7-methyl-2-phenylpyrazolo[1,5-a]pyrimidine-5-carboxylate
por: Bassoude, Ibtissam, et al.
Publicado: (2013)